Trademark Overview
On Friday, January 9, 2026, a trademark application was filed for BYCEMBAL with the United States Patent and Trademark Office. The USPTO has given the BYCEMBAL trademark a serial number of 99587382. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Friday, January 9, 2026. This trademark is owned by Regeneron Pharmaceuticals, Inc.. The BYCEMBAL trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for immunotherapy treatment, cell therapy, and gene therapy; Pharmaceutical preparations for the treatment of auditory, hematological, gastrointestinal, neuromuscular, muscular, cardiovascular, metabolic, immunological, inflammatory, oncological, ophthalmological, neurological, musculoskeletal, bone, connective tissue, dermatological, infectious, autoimmune, nephrological, hepatological, allergic, genetic, respiratory, viral, and pulmonary diseases and disorders; pharmaceutical preparations for the treatment of pain; pharmaceutical preparations for the treatment of obesity